Merit Financial Group, LLC
Position in ADPT — Adaptive Biotechnologies Corp
CIK 1621225
ALPHARETTA, GA
Position in ADPT
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$478,977
New position
Shares Held
5,582
first reported quarter
Ownership
0.003%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 70 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Merit Financial Group, LLC holds $38,936,517 across 18 Diagnostics & Research names. ADPT ranks #14 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
21,998 | $11,028,912 | |
| 2 | NTRA |
Natera, Inc.
|
17,241 | $4,680,066 | |
| 3 | ILMN |
Illumina, Inc.
|
23,473 | $4,127,254 | |
| 4 | DHR |
Danaher Corp /De/
|
19,443 | $3,703,497 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
14,695 | $2,839,364 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
4,310 | $2,282,530 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
4,079 | $2,147,346 | |
| 8 | A |
Agilent Technologies, Inc.
|
14,793 | $1,964,951 |
All Filings in ADPT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $478,977 | 22,330 | Shares | Other | 2026-07-20 | |
| No filing history on record for this holder in this stock. | ||||||